Skip to main content

Table 5 Remission Status by gender, age and history of anxiety and logistic regression analysis to determine the relationship with probability of remission, completers (n = 42)

From: Efficacy, safety and tolerability of escitalopram in doses up to 50 mg in Major Depressive Disorder (MDD): an open-label, pilot study

 

Total in remission (MADRS ≤8)

Total not in remission (MADRS >8)

Odds ratio (95% CI)

P-value

N (% of 42)

21 (50)

21 (50)

  

Gender

    

   Female, n (% of n = 39)

20 (51.3)

19 (48.7)

  

   Male, n (% of n = 3)

1 (33.3)

2 (66.7)

3.33 (0.24-45.76)

0.350

History of anxiety

    

   No, n (% of n = 13)

9 (69.2)

4 (30.8)

  

   Yes, n (% of n = 29)

12 (41.4)

17 (58.6)

4.10 (0.89-18.89)

0.095

Age group

    

   Aged <45, n (% of n = 22)

9 (40.9)

13 (59.1)

  

   Aged ≥45, n (% of n = 20)

12 (60.0)

8 (40.0)

0.44 (0.12-1.63)

0.189

  1. Odds ratios for female vs. male, aged <45 vs. ≥45, no history of anxiety vs. no history of anxiety from logistic regression analysis